Clinical Trial Update: Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN) [Phase 2]

View source ↗

Summary

Phase 2 trial update for patiromer in treating hyperkalemia in patients with hypertension and diabetic nephropathy (AMETHYST-DN) completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperkalemia
• Hypertension

Drugs mentioned

• Patiromer (patiromer)

Snippet

Sponsor: Relypsa, Inc. | Conditions: Chronic Kidney Disease, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-12-17